Analyst Activity Update on Sprint Corporation (NYSE:S), Gilead Sciences, Inc. (NASDAQ:GILD)

May 30, 2017

For the current quarter, analysts are expecting Sprint Corporation (NYSE:S) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Sprint Corporation (NYSE:S) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of N/A%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Sprint Corporation (NYSE:S) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Sprint Corporation (NYSE:S) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

For the current quarter, analysts are expecting Gilead Sciences, Inc. (NASDAQ:GILD) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Gilead Sciences, Inc. (NASDAQ:GILD) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of N/A%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Gilead Sciences, Inc. (NASDAQ:GILD) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Gilead Sciences, Inc. (NASDAQ:GILD) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

By DR Staff Writer

Free Email Newsletter


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Latest Stories